Emanuela Palmerini

Emanuela Palmerini

Oncology

1425 Northwest 10th Avenue
Miami, FL 33136

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 180 publications

TANGENT study design: a phase III, randomized study of emactuzumab for the treatment of tenosynovial giant cell tumors.

TANGENT study design: a phase III, randomized study of emactuzumab for the treatment of tenosynovial giant cell tumors.

Journal: Future oncology (London, England)

Published: July 20, 2026

A modified Delphi consensus on tenosynovial giant cell tumour and giant cell tumour of bone : a report from the Birmingham Orthopaedic Oncology Meeting (BOOM).

A modified Delphi consensus on tenosynovial giant cell tumour and giant cell tumour of bone : a report from the Birmingham Orthopaedic Oncology Meeting (BOOM).

Journal: The bone & joint journal

Published: June 09, 2026

Complications of PI to PIII hemipelvic resections for intermediate and malignant tumours : a systematic review and meta-analysis.

Complications of PI to PIII hemipelvic resections for intermediate and malignant tumours : a systematic review and meta-analysis.

Journal: Bone & joint open

Published: May 31, 2026

Complications of PI to PIII hemipelvic resections for intermediate and malignant tumours : a systematic review and meta-analysis.

Complications of PI to PIII hemipelvic resections for intermediate and malignant tumours : a systematic review and meta-analysis.

Journal: Bone & joint open

Published: May 31, 2026

Team Approach: Diagnosis and Management of Pediatric Pelvic Ewing Sarcoma.

Team Approach: Diagnosis and Management of Pediatric Pelvic Ewing Sarcoma.

Journal: JBJS reviews

Published: May 26, 2026

Editorial: Precision therapeutics in rare cancers: targeting tumor microenvironment and biomarker-driven approaches.

Editorial: Precision therapeutics in rare cancers: targeting tumor microenvironment and biomarker-driven approaches.

Journal: Frontiers in immunology

Published: May 18, 2026

Emerging Treatments in Bone Tumors: Lessons Learned from the ESMO Annual Meeting.

Emerging Treatments in Bone Tumors: Lessons Learned from the ESMO Annual Meeting.

Journal: Biomolecules

Published: May 01, 2026

Paediatric therapeutic development workshop on osteosarcoma.

Paediatric therapeutic development workshop on osteosarcoma.

Journal: British journal of cancer

Published: April 07, 2026

Chondrosarcoma: A comprehensive review of tumor biology, clinical behavior, and therapeutic advances.

Chondrosarcoma: A comprehensive review of tumor biology, clinical behavior, and therapeutic advances.

Journal: Cancer treatment reviews

Published: March 01, 2026

Feasibility and activity of concurrent neoadjuvant chemotherapy and radiation therapy in patients with high-risk soft tissue sarcoma.

Feasibility and activity of concurrent neoadjuvant chemotherapy and radiation therapy in patients with high-risk soft tissue sarcoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 05, 2026

Integrated Immune and Molecular Profiling Identifies Prognostic Subgroups and Therapeutic Targets in Chondrosarcoma.

Integrated Immune and Molecular Profiling Identifies Prognostic Subgroups and Therapeutic Targets in Chondrosarcoma.

Journal: International journal of molecular sciences

Published: January 18, 2026

Reply to: Mifamurtide in Nonmetastatic High-Grade Osteosarcoma.

Reply to: Mifamurtide in Nonmetastatic High-Grade Osteosarcoma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 14, 2026

Showing 1-12 of 180

Last Updated: 09/26/2026